Altimmune urges earlier clinical action on alcohol use disorder and liver disease link

Altimmune urges earlier clinical action on alcohol use disorder and liver disease link
Altimmune pushes for earlier liver care

Altimmune draws attention to the often-overlooked connection between alcohol use disorder and serious liver diseases, calling for a more proactive approach in addressing these intertwined health challenges.

The company advocates closing existing knowledge gaps through enhanced education, initiating clinical conversations at earlier stages, and supporting ongoing research. Altimmune stresses that progress in these areas is needed to improve outcomes for individuals living with severe liver conditions.

Altimmune has previously promoted education on the connection between alcohol consumption and liver health as it works to advance new therapies for severe liver conditions. In May, the company launched an education drive linking alcohol and liver health. The initiative forms part of Altimmune’s strategy to address knowledge gaps in care for liver disease patients.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.